Skip to content

Laparoscopic diagnosis and treatment of traumatic hemothorax volume

Laparoscopic diagnosis and treatment of traumatic hemothorax volume

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-16007943
Enrollment
Unknown
Registered
2016-02-18
Start date
2016-04-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

traumatic hemothorax

Interventions

Research Group:thoracoscopic surgery
control group:Simple drainage

Sponsors

The First Affiliated Hospital of Third Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Between 18 and 65 years of age (including 18 years and 65 years); 2. The imaging diagnosis of traumatic hemothorax; 3. The amount of bleeding 500-1000ml (hemopneumothorax imaging estimation: calculate by regression equation of pleural effusion and pleural effusion volume); 4. No more than 2 rib fractures; 5. Vital signs (blood pressure,breathing rate,heart rate) stable basically; 6. Willingness to participate in the study and to sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Multiple fractures of multiple ribs, flail chest; 2. Cardiac and vascular injury; 3. Rupture of bronchial tube ,diaphragm and esophagus; 4. Serious diseases such as severe heart and brain, liver, kidney, blood, etc.; 5. Lactating or pregnant women; 6. Poor compliance and difficult to complete treatment; 7. Severe immune deficiency; 8. Drug abuse; 9. Patients who are taking part in other clinical trials; 10. Researchers believe that there are other reasons not suitable for clinical trials.

Design outcomes

Primary

MeasureTime frame
Amount of bleeding during operation;Chest drainage;Dynamic changes of hemoglobin concentration from drainage;Chest drainage time;Extubation time;Postoperative pulmonary function;the rate of second chest surgery rate;mortality;Incidence of major complications;

Secondary

MeasureTime frame
Length of stay;Hospitalization expenses;monitor of immune inflammatory reaction index;Degree and duration of pain;quality of life in perioperative period;Patient satisfaction;pulmonary function;Chest CT;Pain score;

Countries

China

Contacts

Public ContactLiu Minghua
309100645@qq.com+86 15998905328

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026